Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance
Clinical trial NCT00046033 · COMPLETED
Trial details
- NCT number
- NCT00046033
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Primary completion
- 2003-03-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.